HIF-1 activity has been associated with worse prognosis in breast cancer [10–12] and is known to drive the upregulation of genes involved in glycolysis, angiogenesis, invasion and a number of other pathologically relevant characteristics [13–16]. Here, HIF1A is linked to breast cancer.